ATE540923T1 - Ää3-(2-amino-1,2-dioxoethyl)-2-ethyl-1- (phenylmethyl)-11h-indol-4-ylüoxyüessigsäure methyl ester als spla2 inhibitor - Google Patents
Ää3-(2-amino-1,2-dioxoethyl)-2-ethyl-1- (phenylmethyl)-11h-indol-4-ylüoxyüessigsäure methyl ester als spla2 inhibitorInfo
- Publication number
- ATE540923T1 ATE540923T1 AT08001265T AT08001265T ATE540923T1 AT E540923 T1 ATE540923 T1 AT E540923T1 AT 08001265 T AT08001265 T AT 08001265T AT 08001265 T AT08001265 T AT 08001265T AT E540923 T1 ATE540923 T1 AT E540923T1
- Authority
- AT
- Austria
- Prior art keywords
- indole
- ylüoxyacetic
- dioxoethyl
- phenylmethyl
- ethyl
- Prior art date
Links
- 239000002253 acid Substances 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
- 150000004702 methyl esters Chemical class 0.000 title 1
- AWMLDBKLOPNOAR-UHFFFAOYSA-N 2-(1h-indol-3-yl)-2-oxoacetamide Chemical class C1=CC=C2C(C(=O)C(=O)N)=CNC2=C1 AWMLDBKLOPNOAR-UHFFFAOYSA-N 0.000 abstract 1
- 206010040070 Septic Shock Diseases 0.000 abstract 1
- 235000014113 dietary fatty acids Nutrition 0.000 abstract 1
- 229930195729 fatty acid Natural products 0.000 abstract 1
- 239000000194 fatty acid Substances 0.000 abstract 1
- 150000004665 fatty acids Chemical class 0.000 abstract 1
- 150000002475 indoles Chemical class 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 230000001404 mediated effect Effects 0.000 abstract 1
- 230000036303 septic shock Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D209/22—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with an aralkyl radical attached to the ring nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Obesity (AREA)
- Immunology (AREA)
- Child & Adolescent Psychology (AREA)
- Cardiology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Enzymes And Modification Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US22191694A | 1994-04-01 | 1994-04-01 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE540923T1 true ATE540923T1 (de) | 2012-01-15 |
Family
ID=22829963
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT08001265T ATE540923T1 (de) | 1994-04-01 | 1995-03-31 | Ää3-(2-amino-1,2-dioxoethyl)-2-ethyl-1- (phenylmethyl)-11h-indol-4-ylüoxyüessigsäure methyl ester als spla2 inhibitor |
| AT95302166T ATE220394T1 (de) | 1994-04-01 | 1995-03-31 | 1h-indol-3-glyoxylamid spla2 inhibitoren |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT95302166T ATE220394T1 (de) | 1994-04-01 | 1995-03-31 | 1h-indol-3-glyoxylamid spla2 inhibitoren |
Country Status (29)
| Country | Link |
|---|---|
| US (6) | US5654326A (de) |
| EP (5) | EP1950200B1 (de) |
| JP (1) | JP3109974B2 (de) |
| KR (1) | KR100368707B1 (de) |
| CN (1) | CN1067054C (de) |
| AT (2) | ATE540923T1 (de) |
| AU (1) | AU688458B2 (de) |
| BR (1) | BR9501404A (de) |
| CA (1) | CA2146097C (de) |
| CO (1) | CO4370099A1 (de) |
| CZ (1) | CZ82295A3 (de) |
| DE (1) | DE69527322T2 (de) |
| DK (2) | DK1950200T3 (de) |
| ES (2) | ES2377223T3 (de) |
| FI (1) | FI114793B (de) |
| HU (1) | HUT72048A (de) |
| IL (1) | IL113210A (de) |
| MX (1) | MX9501608A (de) |
| MY (1) | MY112897A (de) |
| NO (1) | NO304186B1 (de) |
| NZ (1) | NZ270848A (de) |
| PE (1) | PE18696A1 (de) |
| PL (1) | PL180523B1 (de) |
| PT (1) | PT675110E (de) |
| RU (1) | RU2128169C1 (de) |
| SI (1) | SI0675110T1 (de) |
| TW (1) | TW383302B (de) |
| UA (1) | UA47387C2 (de) |
| ZA (1) | ZA952693B (de) |
Families Citing this family (87)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1950200B1 (de) | 1994-04-01 | 2012-01-11 | Eli Lilly And Company | [[3-(2-amino-1,2-dioxoethyl)-2-ethyl-1-(phenylmethyl)-11H-indol-4-yl]oxy]essigsäure methyl ester als sPLA2 inhibitor |
| JPH08193074A (ja) * | 1994-11-18 | 1996-07-30 | Nippon Bayeragrochem Kk | 除草性1−シクロプロピルテトラゾリノン類 |
| CN1092639C (zh) * | 1995-01-06 | 2002-10-16 | 东丽株式会社 | 苯稠合杂环衍生物及其用途 |
| US6630496B1 (en) | 1996-08-26 | 2003-10-07 | Genetics Institute Llc | Inhibitors of phospholipase enzymes |
| DE19636150A1 (de) | 1996-09-06 | 1998-03-12 | Asta Medica Ag | N-substituierte Indol-3-glyoxylamide mit antiasthmatischer, antiallergischer und immunsuppressiver/immunmodulierender Wirkung |
| US5919774A (en) * | 1996-12-10 | 1999-07-06 | Eli Lilly And Company | Pyrroles as sPLA2 inhibitors |
| AU6229298A (en) * | 1997-02-20 | 1998-09-09 | Shionogi & Co., Ltd. | Indole dicarboxylic acid derivatives |
| US5972988A (en) * | 1997-03-26 | 1999-10-26 | Eli Lilly And Company | Method for treatment of chronic bronchitis using indole compounds |
| WO1998047507A1 (en) * | 1997-04-24 | 1998-10-29 | Shionogi & Co., Ltd. | Method for the treatment of stroke using n-heterocyclic glyoxylamide compounds |
| TW455581B (en) * | 1997-06-26 | 2001-09-21 | Lilly Co Eli | Process for preparing 4-substituted-1H-indole-3-glyoxamides |
| US6610728B2 (en) * | 1997-08-28 | 2003-08-26 | Eli Lilly And Company | Method for treatment of non-rheumatoid arthritis |
| EP1030661A4 (de) * | 1997-10-27 | 2002-07-17 | Lilly Co Eli | N,n-diethylglycolamidoester des indols als medikamentvorstufen von spla 2 inhibitoren |
| AU1200899A (en) * | 1997-10-27 | 1999-05-17 | Eli Lilly And Company | Morpholino-n-ethyl ester prodrugs of indole spla2 inhibitors |
| WO1999021545A1 (en) * | 1997-10-27 | 1999-05-06 | Eli Lilly And Company | ISOPROPYL ESTER PRODRUGS OF INDOLE sPLA2 INHIBITORS |
| WO1999024033A1 (en) * | 1997-11-12 | 1999-05-20 | Shionogi & Co., Ltd. | Method for the treatment of disorders associated with apoptosis using n-heterocyclic glyoxylamide compounds |
| EP1039901A1 (de) * | 1997-11-14 | 2000-10-04 | Eli Lilly And Company | Behandlung der alzheimer'schen krankheit |
| JP2001522884A (ja) * | 1997-11-14 | 2001-11-20 | イーライ・リリー・アンド・カンパニー | アルツハイマー病の処置方法 |
| US6828344B1 (en) | 1998-02-25 | 2004-12-07 | Genetics Institute, Llc | Inhibitors of phospholipase enzymes |
| US6916841B2 (en) * | 1998-02-25 | 2005-07-12 | Genetics Institute, Llc | Inhibitors of phospholipase enzymes |
| GEP20032920B (en) * | 1998-02-25 | 2003-03-25 | Genetics Inst | Inhibitors of Phospholipase Enzymes |
| US6500853B1 (en) | 1998-02-28 | 2002-12-31 | Genetics Institute, Llc | Inhibitors of phospholipase enzymes |
| AU757002B2 (en) * | 1998-03-03 | 2003-01-30 | Eli Lilly And Company | Pharmaceutical compositions containing the phospholipase inhibitor sodium ((3-(2-amino-1,2-dioxoethyl)-2-ethyl-1- phenylmethyl)-1H-indol-4-YL)oxy)acetate |
| BR9909345A (pt) | 1998-03-31 | 2000-12-12 | Shionogi & Co | Pirrolo [1,2-a] pirazina inibidor de spla2 |
| CZ302588B6 (cs) * | 1998-04-02 | 2011-07-27 | Ziopharm Oncology, Inc. | Použití N-substituovaného indol-3-glyoxylamidu pro výrobu léciva |
| DE19814838C2 (de) * | 1998-04-02 | 2001-01-18 | Asta Medica Ag | Indolyl-3-glyoxylsäure-Derivate mit Antitumorwirkung |
| DZ2770A1 (fr) | 1998-04-17 | 2003-12-01 | Lilly Co Eli | Procédé de préparation de 1h-indol-3 glyoxamides substituées en position 4. |
| EP1071661A4 (de) * | 1998-04-17 | 2001-08-22 | Lilly Co Eli | Verfahren zur herstellung von 4-hydroxyindol-, indazol- und carbazol-verbindungen |
| US6407261B1 (en) | 1998-04-17 | 2002-06-18 | Eli Lilly And Company | Process for preparing 4-hdyroxy indole, indazole and carbazole compounds |
| EA200001140A1 (ru) * | 1998-05-01 | 2001-04-23 | Эли Лилли Энд Компани | СОЕДИНЕНИЯ-ИНГИБИТОРЫ sPLA2 ДЛЯ ЛЕЧЕНИЯ БОЛЕЗНИ |
| ID27812A (id) * | 1998-05-01 | 2001-04-26 | Lilly Co Eli | ESTER PENGHAMBAT sPLA2 |
| KR20010034881A (ko) | 1998-05-21 | 2001-04-25 | 시오노 요시히코 | sPLA2 억제 효과를 갖는 피롤로[1,2-b]피리다진 유도체 |
| CA2338855A1 (en) | 1998-08-03 | 2000-02-17 | Eli Lilly And Company | Indole spla2 inhibitors |
| JP2002522386A (ja) * | 1998-08-03 | 2002-07-23 | イーライ・リリー・アンド・カンパニー | インドールsPLA2インヒビター |
| WO2000010568A1 (en) | 1998-08-24 | 2000-03-02 | Draheim Susan E | Methods and compositions for treating periodontal disease with an inhibitor of secretory phospholipase a¿2? |
| US6576654B1 (en) | 1998-09-23 | 2003-06-10 | Eli Lilly And Company | Method for the treatment of cystic fibrosis |
| DZ2771A1 (fr) * | 1998-10-09 | 2003-12-01 | Lilly Co Eli | Procédé de préparation de 1h-indol-3 glyoxamides substituées en position 4. |
| DE69931963D1 (de) * | 1998-10-14 | 2006-07-27 | Shionogi & Co | Spla2-inhibitoren zur behandlung von ischämischen reperfusionsschäden |
| US20030149000A1 (en) * | 1998-11-10 | 2003-08-07 | Shionogi & Co., Ltd. | Method for the treatment of disorders associated with apoptosis using N-heterocyclic glyoxylamide compounds |
| CA2358492A1 (en) * | 1998-12-21 | 2000-06-29 | Eli Lilly And Company | Combination therapy for the treatment of sepsis |
| EP1140943B1 (de) * | 1998-12-22 | 2003-08-13 | Eli Lilly And Company | Substituierte pyrroloindole |
| WO2000037358A1 (en) * | 1998-12-22 | 2000-06-29 | Eli Lilly And Company | NOVEL sPLA2 INHIBITORS |
| US6380397B1 (en) | 1999-04-15 | 2002-04-30 | Eli Lilly And Company | Process for preparing 4-substituted-1H-indole-3-glyoxamides |
| US6274578B1 (en) | 1999-04-20 | 2001-08-14 | Eli Lilly And Company | sPLA2 inhibitor ester |
| US6140327A (en) * | 1999-05-12 | 2000-10-31 | Eli Lilly And Company | Morpholino-n-ethyl ester derivative of an indole sPLA2 inhibitor |
| US6706752B1 (en) | 1999-07-19 | 2004-03-16 | Eli Lilly And Company | sPLA2 inhibitors |
| JP4636521B2 (ja) | 1999-07-19 | 2011-02-23 | 塩野義製薬株式会社 | sPLA2阻害作用を有する三環系化合物 |
| DE60032774D1 (de) * | 1999-07-19 | 2007-02-15 | Lilly Co Eli | Spla2 inhibitoren |
| AU6023200A (en) | 1999-08-02 | 2001-02-19 | Shionogi & Co., Ltd. | Tricyclic compounds having spla2-inhibitory activities |
| US6787545B1 (en) | 1999-08-23 | 2004-09-07 | Shiongi & Co., Ltd. | Pyrrolotriazine derivatives having spla2-inhibitory activities |
| WO2001021587A2 (en) * | 1999-09-20 | 2001-03-29 | Eli Lilly And Company | Hydroxyfunctional amide 1h-indole derivatives active as spla2 inhibitors |
| US6831095B1 (en) | 1999-09-20 | 2004-12-14 | Eli Lilly And Company | Hydroxyfunctional amide 1h-indole derivatives active as sPLA2 inhibitors |
| AU7559600A (en) * | 1999-10-15 | 2001-04-23 | Shionogi & Co., Ltd. | V type and/or x type spla2 inhibitors |
| WO2001036420A1 (en) | 1999-11-15 | 2001-05-25 | Shionogi & Co., Ltd. | Tricyclic azaindolizine derivatives having an spla2- inhibiting effect |
| WO2001044184A1 (en) * | 1999-12-16 | 2001-06-21 | Eli Lilly And Company | Synthesis of indole-containing spla2 inhibitors |
| WO2001044185A1 (en) * | 1999-12-16 | 2001-06-21 | Eli Lilly And Company | Carbon monoxide-based synthesis of spla2 inhibitors |
| DE19962300A1 (de) * | 1999-12-23 | 2001-06-28 | Asta Medica Ag | Substituierte N-Benzyl-Indol-3-yl-glyoxylsäure-Derivate mit Antitumorwirkung |
| JP2003519198A (ja) * | 2000-01-06 | 2003-06-17 | イーライ・リリー・アンド・カンパニー | 炎症性疾患および呼吸器疾患の処置のための併用療法 |
| WO2001049662A2 (en) * | 2000-01-07 | 2001-07-12 | Eli Lilly And Company | Carbazole derivatives as inhibitors of spla2 |
| US20030096854A1 (en) * | 2002-06-12 | 2003-05-22 | Ho-Shen Lin | Substituted tricyclics |
| JP2003525901A (ja) * | 2000-03-09 | 2003-09-02 | イーライ・リリー・アンド・カンパニー | sPLA2インヒビターによる腎臓機能障害の治療方法 |
| BR0002188A (pt) * | 2000-03-30 | 2001-11-13 | Brasil Compressores Sa | Processo de formação do pacote de lâminasmetálicas de estator de motor elétrico e pacotede lâminas metálicas |
| AU2001252922A1 (en) * | 2000-04-19 | 2001-11-07 | Eli Lilly And Company | Azide cyclization-based synthesis and intermediates for spla2 inhibitors |
| WO2002000257A1 (en) * | 2000-06-29 | 2002-01-03 | Shionogi & Co., Ltd. | Remedies for alzheimer's disease |
| DE60130891T2 (de) * | 2000-06-29 | 2008-07-17 | Anthera Pharmaceuticals Inc., San Mateo | Heilmittel für krebs |
| WO2002000256A1 (fr) * | 2000-06-29 | 2002-01-03 | Shionogi & Co., Ltd. | Remedes contre la cirrhose |
| AU2001267823A1 (en) * | 2000-06-29 | 2002-01-08 | Shionogi And Co., Ltd. | Compounds exhibiting x-type spla2 inhibiting effect |
| CN1450893A (zh) * | 2000-07-14 | 2003-10-22 | 伊莱利利公司 | 治疗脓毒症的方法 |
| JP2004505982A (ja) * | 2000-08-04 | 2004-02-26 | イーライ・リリー・アンド・カンパニー | 新規なsPLA2インヒビター |
| CA2431506A1 (en) | 2000-12-18 | 2002-07-25 | Eli Lilly And Company | Benz(g) indoles and their use as spla2 inhibitors |
| TWI314457B (de) * | 2001-03-19 | 2009-09-11 | Shionogi & Co | |
| US6730694B1 (en) | 2001-07-20 | 2004-05-04 | Eli Lilly And Company | sPLA2 inhibitors |
| TWI323658B (en) | 2001-12-06 | 2010-04-21 | Nat Health Research Institutes | Novel compounds of indol-3-yl-2-oxyacetylamide derivatives, pharmaceutical composition thereof, and method for manufacturing the same |
| AUPS282602A0 (en) | 2002-06-07 | 2002-06-27 | Garvan Institute Of Medical Research | Method of inhibiting cell proliferation |
| DE10348022A1 (de) * | 2003-10-15 | 2005-05-25 | Imtm Gmbh | Neue Dipeptidylpeptidase IV-Inhibitoren zur funktionellen Beeinflussung unterschiedlicher Zellen und zur Behandlung immunologischer, entzündlicher, neuronaler und anderer Erkrankungen |
| US20050244367A1 (en) * | 2004-05-03 | 2005-11-03 | Ilypsa, Inc. | Phospholipase inhibitors localized in the gastrointestinal lumen |
| JP2009514883A (ja) * | 2005-11-03 | 2009-04-09 | イリプサ, インコーポレイテッド | アザインドール化合物およびホスホリパーゼa2インヒビターとしてのその使用 |
| EP1960356A2 (de) | 2005-11-03 | 2008-08-27 | Ilypsa, Inc. | Mehrwertige indolverbindungen und deren verwendung als phospholipase-a2-inhibitoren |
| EP1948604A1 (de) * | 2005-11-03 | 2008-07-30 | Ilypsa, Inc. | Indolverbindungen mit aciden c4-substituenten und deren verwendung als inhibitoren von phospholipase a2 |
| EP1948602A2 (de) * | 2005-11-03 | 2008-07-30 | Ilypsa, Inc. | Indolverbindungen mit c4-amid-substituenten und ihre verwendung als phospholipase-a2-hemmer |
| US8048880B2 (en) * | 2007-05-03 | 2011-11-01 | Anthera Pharmaceuticals, Inc. | Treatment of cardiovascular disease and dyslipidemia using secretory phospholipase A2 (SPLA2) inhibitors and SPLA2 inhibitor combination therapies |
| EP2272832A4 (de) * | 2008-04-28 | 2011-09-07 | Asahi Kasei Pharma Corp | Phenylpropionsäurederivat und seine verwendung |
| CN102271507A (zh) * | 2009-01-08 | 2011-12-07 | 安塞拉制药有限公司 | 分泌型磷脂酶a2(spla2)抑制剂和烟酸药物组合物以及治疗心血管疾病和血脂异常的方法 |
| CN107233337A (zh) | 2009-04-29 | 2017-10-10 | 阿马里纳药物爱尔兰有限公司 | 含有epa和心血管剂的药物组合物以及使用其的方法 |
| CN101838232B (zh) * | 2009-07-07 | 2012-02-22 | 爱斯医药科技(南京)有限公司 | Varespladib的制备方法 |
| MA40998A (fr) | 2014-11-21 | 2017-09-26 | Ophirex Inc | Thérapies contre une envenimation, ainsi que compositions, systèmes et kits pharmaceutiques associés |
| JP2018526440A (ja) * | 2015-08-31 | 2018-09-13 | ディアキュレートDiaccurate | 免疫系を刺激するためのインドール化合物の使用 |
| CN109562098B (zh) * | 2016-04-29 | 2023-04-21 | 奥菲瑞克斯股份有限公司 | 用于立即治疗膜翅目注毒和其他因组胺释放引起的病症的pla2抑制剂 |
Family Cites Families (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2825734A (en) | 1955-04-11 | 1958-03-04 | Upjohn Co | Reduction of carbonylic radicals in indolyl-3 compounds |
| US2825743A (en) | 1955-08-30 | 1958-03-04 | Celanese Corp | Catalytic hydrogenation of unsaturated aldehydes and ketones |
| US3242163A (en) * | 1961-03-13 | 1966-03-22 | Merck & Co Inc | Indolyl aliphatic acids |
| US3259622A (en) * | 1962-09-07 | 1966-07-05 | Merck & Co Inc | 1-benzyl-3-indolyl-alpha-haloalkyl and alkylidenyl acetic acids |
| GB1089071A (en) | 1964-02-28 | 1967-11-01 | Merck & Co Inc | Indole derivatives |
| NL287416A (de) | 1964-04-25 | |||
| US3449363A (en) | 1966-12-22 | 1969-06-10 | American Cyanamid Co | 3-substituted 4-trifluoromethyl indoles |
| IT1036004B (it) * | 1968-05-21 | 1979-10-30 | Abc Ist Biolog Chem Spa | Acidt 3 indolil adetoidrossamici |
| US3691194A (en) * | 1970-07-30 | 1972-09-12 | Little Inc A | 3-indole-glyoxamides |
| US3686213A (en) | 1970-08-28 | 1972-08-22 | American Cyanamid Co | Substituted aminoethyl indoles |
| US4012513A (en) * | 1971-11-03 | 1977-03-15 | Imperial Chemical Industries Limited | Indole derivatives for providing analgesic and anti-inflammatory effects |
| US4397850A (en) | 1981-10-07 | 1983-08-09 | Sandoz, Inc. | Isoxazolyl indolamines |
| US4552876A (en) * | 1984-07-09 | 1985-11-12 | Usv Pharmaceutical Corp. | Bisbenzoxazines and pharmaceutical use |
| US4743609A (en) * | 1985-02-12 | 1988-05-10 | Banyu Pharmaceutical Co., Ltd. | Indole derivatives having gastric and antisecretory and cytoprotective properties, and pharmaceutical preparations containing same |
| US4792555A (en) * | 1987-03-20 | 1988-12-20 | American Home Products Corporation | Phospholipase A2 inhibitors |
| NZ234883A (en) * | 1989-08-22 | 1995-01-27 | Merck Frosst Canada Inc | Quinolin-2-ylmethoxy indole derivatives, preparation and pharmaceutical compositions thereof |
| US5420289A (en) * | 1989-10-27 | 1995-05-30 | American Home Products Corporation | Substituted indole-, indene-, pyranoindole- and tetrahydrocarbazole-alkanoic acid derivatives as inhibitors of PLA2 and lipoxygenase |
| PT95692A (pt) * | 1989-10-27 | 1991-09-13 | American Home Prod | Processo para a preparacao de derivados de acidos indole-,indeno-,piranoindole- e tetra-hidrocarbazole-alcanoicos, ou quais sao uteis como inibidores de pla2 e da lipoxigenase |
| US5192770A (en) | 1990-12-07 | 1993-03-09 | Syntex (U.S.A.) Inc. | Serotonergic alpha-oxoacetamides |
| US5334719A (en) * | 1992-06-17 | 1994-08-02 | Merck Frosst Canada, Inc. | Bicyclic(azaaromatic)indoles as inhibitors of leukotriene bisynthesis |
| IL109311A0 (en) * | 1993-04-16 | 1994-07-31 | Lilly Co Eli | 1H-indole-3-acetamide sPla2 inhibitors |
| IL109309A (en) * | 1993-04-16 | 2000-06-29 | Lilly Co Eli | 1-H-indole-3-acetic acid hydrazide SPLA2 inhibitors and pharmaceutical compositions containing them |
| EP1950200B1 (de) | 1994-04-01 | 2012-01-11 | Eli Lilly And Company | [[3-(2-amino-1,2-dioxoethyl)-2-ethyl-1-(phenylmethyl)-11H-indol-4-yl]oxy]essigsäure methyl ester als sPLA2 inhibitor |
| US5639780A (en) * | 1995-05-22 | 1997-06-17 | Merck Frosst Canada, Inc. | N-benzyl indol-3-yl butanoic acid derivatives as cyclooxygenase inhibitors |
| PL327146A1 (en) * | 1995-12-14 | 1998-11-23 | Merck & Co Inc | Antagonists of the gonadotrophin liberating hormone |
| KR19990072124A (ko) | 1995-12-14 | 1999-09-27 | 애쉬톤 왈레이스 티 | 고나도트로핀 방출 호르몬의 길항제 |
| EP1030661A4 (de) * | 1997-10-27 | 2002-07-17 | Lilly Co Eli | N,n-diethylglycolamidoester des indols als medikamentvorstufen von spla 2 inhibitoren |
-
1995
- 1995-03-31 EP EP08001265A patent/EP1950200B1/de not_active Expired - Lifetime
- 1995-03-31 MX MX9501608A patent/MX9501608A/es unknown
- 1995-03-31 AT AT08001265T patent/ATE540923T1/de active
- 1995-03-31 CO CO95013251A patent/CO4370099A1/es unknown
- 1995-03-31 CA CA002146097A patent/CA2146097C/en not_active Expired - Fee Related
- 1995-03-31 ZA ZA952693A patent/ZA952693B/xx unknown
- 1995-03-31 PE PE1995265383A patent/PE18696A1/es not_active Application Discontinuation
- 1995-03-31 HU HU9500957A patent/HUT72048A/hu unknown
- 1995-03-31 CN CN95103320A patent/CN1067054C/zh not_active Expired - Fee Related
- 1995-03-31 TW TW084103168A patent/TW383302B/zh not_active IP Right Cessation
- 1995-03-31 KR KR1019950007267A patent/KR100368707B1/ko not_active Expired - Fee Related
- 1995-03-31 MY MYPI95000820A patent/MY112897A/en unknown
- 1995-03-31 SI SI9530616T patent/SI0675110T1/xx unknown
- 1995-03-31 PL PL95307951A patent/PL180523B1/pl not_active IP Right Cessation
- 1995-03-31 NO NO951252A patent/NO304186B1/no not_active IP Right Cessation
- 1995-03-31 RU RU95104885/04A patent/RU2128169C1/ru not_active IP Right Cessation
- 1995-03-31 DK DK08001265.1T patent/DK1950200T3/da active
- 1995-03-31 DK DK95302166T patent/DK0675110T3/da active
- 1995-03-31 EP EP10180825A patent/EP2341045A1/de not_active Withdrawn
- 1995-03-31 CZ CZ95822A patent/CZ82295A3/cs unknown
- 1995-03-31 ES ES08001265T patent/ES2377223T3/es not_active Expired - Lifetime
- 1995-03-31 UA UA95038298A patent/UA47387C2/uk unknown
- 1995-03-31 EP EP95302166A patent/EP0675110B1/de not_active Expired - Lifetime
- 1995-03-31 AU AU16217/95A patent/AU688458B2/en not_active Ceased
- 1995-03-31 NZ NZ270848A patent/NZ270848A/en unknown
- 1995-03-31 DE DE69527322T patent/DE69527322T2/de not_active Expired - Lifetime
- 1995-03-31 EP EP00203897A patent/EP1081135A3/de not_active Withdrawn
- 1995-03-31 ES ES95302166T patent/ES2179088T3/es not_active Expired - Lifetime
- 1995-03-31 FI FI951553A patent/FI114793B/fi not_active IP Right Cessation
- 1995-03-31 PT PT95302166T patent/PT675110E/pt unknown
- 1995-03-31 EP EP01130290A patent/EP1197484A2/de not_active Withdrawn
- 1995-03-31 AT AT95302166T patent/ATE220394T1/de active
- 1995-03-31 IL IL11321095A patent/IL113210A/en not_active IP Right Cessation
- 1995-03-31 BR BR9501404A patent/BR9501404A/pt not_active IP Right Cessation
- 1995-03-31 JP JP07076117A patent/JP3109974B2/ja not_active Expired - Fee Related
- 1995-06-06 US US08/469,954 patent/US5654326A/en not_active Expired - Lifetime
-
1997
- 1997-03-28 US US08/825,453 patent/US5733923A/en not_active Expired - Lifetime
- 1997-05-14 US US08/856,271 patent/US5919810A/en not_active Expired - Lifetime
- 1997-12-16 US US08/991,149 patent/US5919943A/en not_active Expired - Lifetime
-
1999
- 1999-02-26 US US09/258,680 patent/US6175021B1/en not_active Expired - Fee Related
-
2000
- 2000-11-16 US US09/714,364 patent/US6433001B1/en not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1950200T3 (da) | [[3-(2-AMINO-1,2-DIOXOETHYL)-2-ETHYL-1-(PHENYLMETHYL)-11H-INDOL-4-YL]OXY]EDDIKESYREMETHYLESTER SOM sPLA2-INHIBITOR | |
| ATE296286T1 (de) | Morpholino-n-ethyl ester prodrogen von indol spla 2 hemmer | |
| RU94012931A (ru) | Гидразиды 1н-индол-3-уксусной кислоты как ингибиторы spla2 | |
| NO941361D0 (no) | 1H-indol-3-acetamid sPLA2-inhibitorer | |
| DE69724009D1 (de) | PYRROLE ALS sPLA2 INHIBITOREN | |
| ATE203744T1 (de) | Naphthyl-acetamide als spla2-inhibitoren | |
| ATE326963T1 (de) | Indolverbindungen als spla2 inhibitoren | |
| DE69720034D1 (de) | PHENYLGLYOXAMIDE ALS sPLA2-INHIBITOREN | |
| DE60032774D1 (de) | Spla2 inhibitoren | |
| ATE353876T1 (de) | Substituierte carbazole als inhibitoren von spla2 | |
| BR0010448A (pt) | éster de morfolino-n-etila derivado de um inibidor de spla2 de indol | |
| DE60032254D1 (de) | Hydroxyfunktionelle amid-1h-indolderivate aktiv als spla2 inhibitoren | |
| WO2002050028A3 (en) | Substituted benzoindoles as spla2 inhibitors | |
| DE60126831D1 (de) | Benz(g)indole und deren verwendung als spla2 inhibitoren | |
| WO2001049662A3 (en) | Carbazole derivatives as inhibitors of spla2 |